-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$12.00574.16% Upside
Werewolf Therapeutics, Inc. Frequently Asked Questions
-
What analysts cover Werewolf Therapeutics, Inc.?
Werewolf Therapeutics, Inc. has been rated by research analysts at JMP Securities in the past 90 days.